Reply: To PMID 25283701.
作者信息
Silberstein Jonathan L, Sartor Oliver A
机构信息
Department of Urology, Tulane University School of Medicine, New Orleans, LA; Department of Hematology and Medical Oncology, Tulane University School of Medicine, New Orleans, LA.
出版信息
Urology. 2014 Dec;84(6):1262. doi: 10.1016/j.urology.2014.06.066. Epub 2014 Oct 3.
Abstract
摘要
相似文献
1
Reply: To PMID 25283701.
Urology. 2014 Dec;84(6):1262. doi: 10.1016/j.urology.2014.06.066. Epub 2014 Oct 3.
2
Editorial comment.
Urology. 2014 Dec;84(6):1261-2. doi: 10.1016/j.urology.2014.06.065. Epub 2014 Oct 3.
3
Active surveillance of prostate cancer in African American men.
Urology. 2014 Dec;84(6):1255-61. doi: 10.1016/j.urology.2014.06.064. Epub 2014 Oct 3.
4
[Reply].
Urologe A. 2015 Jun;54(6):870.
5
Active Surveillance for Black Men with Low-Risk Prostate Cancer in the United States.
N Engl J Med. 2019 Dec 26;381(26):2581-2582. doi: 10.1056/NEJMc1912868.
6
[Active surveillance of low risk prostate cancer].
Urologe A. 2015 Jun;54(6):869-70. doi: 10.1007/s00120-015-3804-5.
7
Race/ethnicity and the intensity of medical monitoring under 'watchful waiting' for prostate cancer.
Med Care. 2004 Mar;42(3):239-50. doi: 10.1097/01.mlr.0000117361.61444.71.
8
Reply.
Urology. 2015 Nov;86(5):997. doi: 10.1016/j.urology.2015.07.044.
9
Prostate cancer: treatment triggers for patients on active surveillance.
Nat Rev Urol. 2011 Mar;8(3):126-7. doi: 10.1038/nrurol.2010.235. Epub 2011 Jan 18.
10
Prostate cancer: reducing overtreatment: active surveillance in low-risk disease.
Nat Rev Urol. 2011 Mar;8(3):124-5. doi: 10.1038/nrurol.2011.8. Epub 2011 Feb 8.
Zotero 插件